Growth Metrics

Sanara MedTech (SMTI) Cash from Investing Activities (2016 - 2025)

Sanara MedTech's Cash from Investing Activities history spans 14 years, with the latest figure at -$2.4 million for Q4 2025.

  • For Q4 2025, Cash from Investing Activities fell 1781.07% year-over-year to -$2.4 million; the TTM value through Dec 2025 reached -$15.0 million, down 126.48%, while the annual FY2025 figure was -$15.0 million, 126.48% down from the prior year.
  • Cash from Investing Activities reached -$2.4 million in Q4 2025 per SMTI's latest filing, up from -$3.4 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of -$12945.0 in Q2 2023 to a low of -$10.1 million in Q3 2023.
  • Average Cash from Investing Activities over 5 years is -$2.0 million, with a median of -$677399.0 recorded in 2021.
  • Peak YoY movement for Cash from Investing Activities: skyrocketed 99.38% in 2023, then tumbled 7769.97% in 2025.
  • A 5-year view of Cash from Investing Activities shows it stood at -$1.5 million in 2021, then skyrocketed by 74.73% to -$376954.0 in 2022, then soared by 85.6% to -$54276.0 in 2023, then crashed by 139.51% to -$129994.0 in 2024, then tumbled by 1781.07% to -$2.4 million in 2025.
  • Per Business Quant, the three most recent readings for SMTI's Cash from Investing Activities are -$2.4 million (Q4 2025), -$3.4 million (Q3 2025), and -$3.9 million (Q2 2025).